Vaxcyte (NASDAQ: PCVX) completed patient enrollment in the Phase 2 portion of the ongoing Phase 1/2 proof-of-concept study evaluating VAX-24 in healthy adults 50 to 64 years of age.
On Wednesday, Apple, Inc (NASDAQ: AAPL) announced a Self Service Repair program to allow customers to replace broken and damaged parts for some devices at home beginning in the U.S. in early 2022.
electroCore, Inc. (NASDAQ:ECOR) (the "Company"), a commercial-stage bioelectronic medicine and wellness company, today announced a planned reverse stock split of its shares of common stock at a ratio of